Cargando…

Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study

Detalles Bibliográficos
Autores principales: Anandaradje, Annuja, Goenka, Luxitaa, Dubashi, Biswajit, Kayal, Smita, Halanaik, Dhanapati, Basu, Debdatta, Ganesan, Prasanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404067/
http://dx.doi.org/10.1016/S2152-2650(21)01531-7
_version_ 1783746093234782208
author Anandaradje, Annuja
Goenka, Luxitaa
Dubashi, Biswajit
Kayal, Smita
Halanaik, Dhanapati
Basu, Debdatta
Ganesan, Prasanth
author_facet Anandaradje, Annuja
Goenka, Luxitaa
Dubashi, Biswajit
Kayal, Smita
Halanaik, Dhanapati
Basu, Debdatta
Ganesan, Prasanth
author_sort Anandaradje, Annuja
collection PubMed
description
format Online
Article
Text
id pubmed-8404067
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84040672021-08-30 Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study Anandaradje, Annuja Goenka, Luxitaa Dubashi, Biswajit Kayal, Smita Halanaik, Dhanapati Basu, Debdatta Ganesan, Prasanth Clin Lymphoma Myeloma Leuk Article Elsevier Inc. 2021-09 2021-08-30 /pmc/articles/PMC8404067/ http://dx.doi.org/10.1016/S2152-2650(21)01531-7 Text en Copyright © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Anandaradje, Annuja
Goenka, Luxitaa
Dubashi, Biswajit
Kayal, Smita
Halanaik, Dhanapati
Basu, Debdatta
Ganesan, Prasanth
Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title_full Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title_fullStr Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title_full_unstemmed Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title_short Poster: ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
title_sort poster: abcl-334: impact of covid-19 pandemic on treatment duration in curable cancers: comparison of patients with dlbcl treated before and during: a retrospective record-based study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404067/
http://dx.doi.org/10.1016/S2152-2650(21)01531-7
work_keys_str_mv AT anandaradjeannuja posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT goenkaluxitaa posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT dubashibiswajit posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT kayalsmita posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT halanaikdhanapati posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT basudebdatta posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy
AT ganesanprasanth posterabcl334impactofcovid19pandemicontreatmentdurationincurablecancerscomparisonofpatientswithdlbcltreatedbeforeandduringaretrospectiverecordbasedstudy